Beijing Mabworks Biotech

Developer of anticancer therapies

placeBeijing, Beijing, China calendar_todayFounded 2003 groups285 employees language mab-works.com

Investor mix

16 investors on record; lead investors include Paradise Silicon Valley Asset Management Group, ShenZhen GTJA Investment Group, Medfine Capital.

Investor typeCountShare
Venture capital956%
Private equity638%
Other / undisclosed16%
Coming soon